SUMMARY Skin rashes, proteinuria, systemic lupus erythematosus, polymyositis and myasthenia gravis have all been recorded as complications of penicillamine therapy in patients with rheumatoid arthritis. A patient who has developed all 5 is now described. The skin lesion resembled elastosis perforans serpiginosa, which has been reported as a rare side effect in patients with Wilson's disease but not in patients with rheumatoid arthritis treated with penicillamine.
blood investigations were normal, and x-rays of the chest, hands, and feet did not show any abnormality either. A diagnosis of seropositive, nonerosive rheumatoid arthritis was made, and he was admitted to hospital for a period of bed rest and treatment with nonsteroidal anti-inflammatory agents.
Although his initial progress was satisfactory, the activity of the disease was not well controlled, and in January 1974 D-penicillamine was introduced in addition to standard medications, the dose being gradually increased to 900 mg per day. During the following 4 years his disease was characterised by several exacerbations and remissions.
In November 1977 penicillamine had to be discontinued on account of proteinuria, but it was reintroduced in a daily dose of 250 mg when the urine became albumin-free. In spite of continuous therapy with nonsteroidal anti-inflammatory agents and D-penicillamine the arthritis progressed to involve practically all joints, especially the wrists, elbows, and hands, and a few rheumatoid nodules appeared. The haemoglobin was found to be 9 g/dl; serum iron 3 ,umo1lI; total iron binding capacity 63 ,smol/l; levels of red cell folate and serum B,2 were normal, as were liver function tests, blood urea, creatinine, and electrolytes. Several specimens of stool were examined for occult blood and in one specimen a trace was found. Examination of bone marrow showed normoblastic hyperplasia and erythropoiesis with normal haemopoiesis and megakaryocytes; no free iron was demonstrated. A barium meal did not show any abnormality.
At this stage prednisolone 12-5 mg was added to the other medications. Considerable improvement followed, and the patient was able to return to work after a few months' incapacity. In due course it was possible to reduce the dose of prednisolone to 5 mg per day. In August 1979 a pruritic skin lesion resembling erythema annulare centrifugum appeared over the right shoulder and upper chest and in the right axilla (Figs. 1-3) . Biopsy from the edge of one of the lesions revealed a mononuclear infiltrate in the mid-dermis, with destruction of the collagen bundles. The appearance was thought to be nonspecific but possibly representing an unusual reaction to penicillamine, which was therefore discontinued. The skin lesions gradually disappeared, and a few months later penicillamine was restarted in a daily dose of 125 mg, other medications at that time consisting of prednisolone 7-5 mg and indomethacin 25 mg per day.
In July 1980 the patient was admitted on account of intermittent fever during the preceding few months, poor appetite, and considerable weight loss. Investigations showed an ESR of 91 mm/h rising to 110 mm/h; haemoglobin 14 g/dl; white cell count 10 8 x 109/l (10 800 per mm3) with normal differential. Several blood cultures and examination of sputum were negative. No malaria parasites were seen in the blood film. Salmonella and brucella agglutination tests were normal. Antinuclear factor was positive 1/10, increasing to 1/10 240; anti-DNA (double-stranded) antibodies were within normal range and scanty LE cells were seen in the blood film. Liver function tests were persistently raised, but liver biopsy was normal.
It was thought that the patient had developed lupus erythematosus, possibly as a complication of penicillamine therapy. This was discontinued, and when the prednisolone was increased to 60 mg a day his temperature came down to normal within 24 hours and remained normal, ultimately allowing the dose of prednisolone to be reduced to 10 mg. However, after a few days he developed severe pain and stiffness in most of the joints, and penicillamine was started again in a dose of 250 mg a day. His symptoms settled down very satisfactorily, and he was able to return to his usual occupation.
A few weeks after discharge from hospital he complained of some difficulty in swallowing and in talking. Penicillamine was immediately discontinued on the assumption that he had developed myasthenia gravis which was drug-induced. In (Figs. 1-3) , and it may well be that these are the same as the ones described by Pass et 
